Oura publicly files for initial public offering, looks to raise $2.2 billion

Oura, a health tracking ring maker, filed for an IPO aiming to raise $2.2B by selling 50M shares at $40-$44 each, listing on Nasdaq as OURA. The company reported $1.2B revenue for the nine months ending June 30, up from $697M last year, with a net loss of $924M. It sold 4.1M rings and has 5M paid subscription members.

Original reporting
Published Sep 21, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 3:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Oura publicly files for initial public offering, looks to raise $2.2 billion — source image
Decision brief

The 30-second read

High
01

Why it matters

The filing introduces a sizable new IPO in the consumer‑tech space, offering investors exposure to a niche wearables market with strong subscription revenue growth.

02

Market read

The IPO could attract both growth‑oriented investors and those seeking exposure to health‑data platforms, influencing wearables sector dynamics.

03

What to watch

Regulatory scrutiny of health data privacy and subscription churn could affect long‑term profitability.

Relevance 9/10Novelty 9/10Timing: IPO filing announced today

Background

Oura, a Finnish maker of health‑tracking rings, filed its S‑1 to list on Nasdaq under the ticker OURA, seeking to raise up to $2.2 billion.

Market effects

Adds a new public player to the health‑tracking wearables sector, increasing competition for Fitbit and Apple.

Highlights Finnish tech's move into US capital markets, may boost Nordic tech sentiment.

Potentially broadens investor exposure to consumer health data platforms worldwide.

Counterpoint

The IPO may be over‑hyped; valuation could be stretched given ongoing net losses.

Key entities

  • Oura

    Finnish health‑tracking ring manufacturer planning Nasdaq IPO.

Related articles

Med

Nelson Advisors: Strategic Patent Litigation in the Wearables Market - Analysis of Oura Ring v UltraHuman and SVTronics

Ouraring Inc. sued Ultrahuman and SVTronics Inc. for patent infringement in the U.S. District Court for the Eastern District of Texas, alleging Ultrahuman's Ring Pro infringes its design and utility patents. Oura seeks injunctive relief and damages, including treble damages for willful infringement. This follows an earlier ITC ruling excluding Ultrahuman's Ring Air from the U.S. market.

HighAI 9/10

Oura IPO Postponed as Kalshi Traders Rethink 2026 Debuts

Oura, a sleep-tracking ring company, postponed its IPO despite a 99% predicted chance, citing market conditions. It reported $1.2B revenue and $60.8M net income for 2026. The delay reflects broader IPO market slowdown, with only 30 U.S. IPOs in Q3 2026, down from 64 in 2025.

MedAI 8/10

Smart Ring Maker Oura Delays Nasdaq IPO, Citing Market Uncertainty

Oura, a smart ring maker, delayed its Nasdaq IPO citing market uncertainty. The company aimed to sell 50M shares, raising up to $2.2B at a $15B valuation. Oura reported strong earnings, with $907.8M revenue and $23.5M pretax profit in fiscal 2025. The delay follows a lawsuit alleging false advertising, but the company denies this influenced the decision.

Low

Oura postpones its $2.2bn IPO, citing market uncertainty

Oura postponed its $2.2bn IPO, citing market uncertainty despite strong demand. It planned to sell 50M shares at $40-$44 each. The company is profitable, with 5.7M paid members and expects 90% revenue growth in 2026. Four companies postponed IPOs in the same week, according to Renaissance Capital.